Total Face Group - Skin clinic
Total Face Group - Skin clinic

TOTAL FACE GROUP

Total Face Group Ltd ACN 169 177 833

Investor centre

12/10/2018
Change in substantial holding
11/10/2018
Ceasing to be a substaintial Holder – Paul Fielding
10/10/2018
Amended Appendix 3B – GBCo consideration
10/10/2018
Appendix 3Y – C Parkes Interests
10/10/2018
Appendix 3Y – K Poutakidis Interests
10/10/2018
Appendix 4C – Quarterly Cash Flow
10/10/2018
Incoming CEO Letter to Shareholders
10/10/2018
Initial notice of substantial holder – GBC Investments Pty Ltd
10/10/2018
Market Update
09/10/2018
Appendix 3B – GBCo consideration
09/10/2018
Cleansing Prospectus
08/10/2018
Appendix 3B – Rights Offer Acceptance
05/10/2018
Appendix 3B
28/09/2018
Capital Raising Placement
27/09/2018
Appointment of CEO and Managing Director
27/09/2018
Chairman’s Address to Shareholders
27/09/2018
Final Directors interest notice – Paul Fielding
27/09/2018
Initial Directors interest notice – Christine Parkes
27/09/2018
Results of Meeting
26/09/2018
Chairman Resignation
18/09/2018
Appendix 3B – Rights Offer
18/09/2018
Offer Information Statement – Final
31/08/2018
Annual Report 2018
31/08/2018
Appendix 4E FY18 Results Announcement
31/08/2018
Appendix 4G Key to Corporate Governance Disclosures
28/08/2018
Appendix 3X Initial Directors Interest Notice
28/08/2018
Director Appointment
27/08/2018
Appendix_03X (1) – Ken Poutakidis
27/08/2018
General Meeting Proxy
27/08/2018
Notice of General Meeting
27/08/2018
TFG 2018 GM Proxy 27.8.18 FINAL
27/08/2018
TFG Notice of Meeting – August 2018 – FINAL
19/08/2018
Appendix 3B – Rights Offer
19/08/2018
Offer Information Statement
13/07/2018
Appendix 4C- Quarterly Cash flow
05/07/2018
Final directors interest notice
04/07/2018
ASX Announcement – Company Update
02/05/2018
Asset Sale & Legal Proceeding Update
02/05/2018
Final Directors Interest Notice
30/04/2018
Quarterly Update & Appendix 4C
17/04/2018
CEO Resignation
28/02/2018
Half Yearly Report & Accounts
19/02/2018
Strategic Review Update & Financing
19/02/2018
Suspension from Official Quotation
15/02/2018
Trading Halt Request
31/01/2018
Quarterly Update & Appendix 4C
22/01/2018
Appendix 3B – Release from escrow
10/01/2018
Release of securities from escrow
04/01/2018
Allergan takes control of CoolSculpting in Australia
19/12/2017
Strategic Review & Legal Proceedings
28/11/2017
2017 AGM Results of Meeting
28/11/2017
AGM Investor Update
28/11/2017
Chairman’s Address to Shareholders
13/11/2017
Appendix 3B Secured Redeemable Convertible Notes
13/11/2017
Secured Redeemable Convertible Notes
03/11/2017
Appendix 3B- Artisan Cosmetic & Rejuvenation Clinic
30/10/2017
Acquisition of Artisan Cosmetic & Rejuvenation Clinic
30/10/2017
Quarterly Update & Appendix 4C
27/10/2017
2017 AGM Proxy Form
27/10/2017
Notice of Annual General Meeting
18/10/2017
Strategic Review Update
27/09/2017
Appendix 3B COZmedics Post Completion
31/08/2017
2017 Annual Report
31/08/2017
Appendix 4E FY17 Results
31/08/2017
Appendix 4G Corporate Governance Key to Disclosures
31/08/2017
Board to undertake Strategic Review & FY17 Result
31/08/2017
Long Term Incentive Plan
31/08/2017
Long Term Incentive Plan Rules
31/07/2017
June 2017 Quarterly 4C
04/07/2017
Appendix 3B- Convertible Note Final
04/07/2017
Convertible Note & FY17 Operations Update
13/06/2017
Change of Directors interest notice
08/06/2017
Appendix 3B- Convertible note
08/06/2017
Convertible Note
03/05/2017
Appendix 3B – Face Today & Rejuven8 Post Completion Issue
03/05/2017
Appendix 3X- Initial Directors Interest Notice
03/05/2017
Director Appointment
27/04/2017
Appendix 4C & Quarterly Update
27/02/2017
Appendix 4D & Half Year Financial Report
27/02/2017
TFG Half Year Dec 2016 Results Presentation
06/02/2017
Appendix 3B- Release from escrow
30/01/2017
Quarterly Update & Appendix 4C
25/01/2017
25 Jan Becoming a substantial holder
24/01/2017
Leadership Team Appointments
09/01/2017
Final Directors Interest Notice
09/01/2017
Release from escrow
08/12/2016
Paragon Care supply agreement with TFG
07/12/2016
Shareholder Newsletter & Discount Card
30/11/2016
Board of Directors Changes
18/11/2016
Gordon Capital Update November 2016
18/11/2016
Removal of Initiation Paper
15/11/2016
AGM Investor Update
15/11/2016
Results of Annual General Meeting
28/10/2016
Quarterly Update & Appendix 4C
14/10/2016
Annual General Meeting Proxy Form
14/10/2016
Notice of Annual General Meeting
10/10/2016
Appendix 3B- Release from escrow
06/10/2016
Director Appointment- Dr Naveen Somia
06/10/2016
Initial Directors Interest Notice- Dr Naveen Somia
23/09/2016
Release from escrow
21/09/2016
Change of Directors Interests Notice
14/09/2016
Investor Update September 2016
08/09/2016
Appendix 3B- Heber Davis Post Completion Share Issue
06/09/2016
Appendix 3B- COZmedics Post Completion Share Issue
31/08/2016
Appendix 4G
31/08/2016
Appendix 4E
31/08/2016
Annual Report
08/08/2016
Business Chicks Strategic Partnership
29/07/2016
Appendix 4C- Quarter ended 30 June 2016
29/07/2016
Ceasing to be a substantial holder
21/07/2016
TFG Completes Facial Artistry Acquisition
19/07/2016
TFG Completes Acquisition of COZmedics & Endless Solutions
19/07/2016
Appendix 3B & Cleansing Notice
15/07/2016
TFG COMPLETES CoolSculpting® EXPANSION CONTRACTS
11/07/2016
Results of TFG General Meeting
11/07/2016
TFG GM CEO Address
21/06/2016
COZmedics Execution of Business Sale & Purchase Agreements
17/06/2016
Facial Artistry & Endless Solutions Execution of Business Sale
09/06/2016
Rereleased Investor Presentation - June 2016
09/06/2016
ASX Announcement - $10M Capital Raising
09/06/2016
TFG Sample Proxy Form
09/06/2016
$10M Capital Raising Presentation
09/06/2016
Notice of General Meeting To Be Held On 11 July 2016
07/06/2016
ASX Announcement - Trading Halt Combined Announcement
23/05/2016
ASX Announcement - Greenfields Sites
28/04/2016
ASX Release Quarterly Report
26/04/2016
Appendix 3B - New Issue Announcement
08/04/2016
Release of Securities From Escrow
17/03/2016
TFG Investor Presentation
10/03/2016
TFG Secures Retail Finance Agreement
02/03/2016
TFG Acquires Lase By The Sea Laser and Cosmetic Clinic
02/03/2016
Appendix 3B - Lase By The Sea
29/02/2016
Half Year Results Release to Australian Stock Exchange
24/02/2016
TFG Acquires Rejuven8 Cosmetic Clinic
04/02/2016
Becoming a Substantial Shareholder - MC
03/02/2016
Acquisition of Face Today Mediclinic
01/02/2016
Amended Appendix 4C - quarterly
29/01/2016
Appendix 4C - quarterly
20/01/2016
Appendix 3B
20/01/2016
Form 603 Paul Fielding
20/01/2016
Form 603 TFG
19/01/2016
Initial Directors Interest - Vilma Di Maria
19/01/2016
Initial Directors Interests - Joanne Hannah
19/01/2016
Initial Directors Interests - John Conidi
19/01/2016
Initial Directors Interests - Paul Fielding
14/01/2016
Statement of Restricted Securities
14/01/2016
Code of Conduct for Transactions in Securities
14/01/2016
Long Term Incentive Plan Rules
14/01/2016
Long Term Incentive Plan
14/01/2016
Constitution
14/01/2016
Supplementary Prospectus
14/01/2016
Replacement Prospectus
13/01/2016
Audited 2015 Accounts
13/01/2016
Information Form & Checklist
13/01/2016
Appendix 1A
13/01/2016
Top 20 Holders
13/01/2016
Distribution Schedule
The Board's responsibility to oversee the operations of the business is based on the foundation of honesty and integrity. This Charter establishes an overall framework for the corporate governance and control of the Company with regard to the interests of stakeholders. The role of the Audit & Risk Committee is to assist the Board in implementing an effective corporate governance framework. This Charter outlines the specific responsibilities, delegated authority and composition of the Committee. To assist the Board in its role of monitoring the performance of the Company, this policy outlines the process to evaluate how effectively the Board, Directors and Committees are performing their duties and obligations imposed by the Company and by the law. To enhance investor confidence, this policy demonstrates the commitment of the Company to ethical standards and practices. It provides Directors and Officers with a guide to acceptable behaviour intended to protect the interests of shareholders, staff, clients and all other stakeholders in the Company. Legal constraints applicable to Directors, Officers and relevant employees of listed companies dealing in securities in the Company arise from common law, the Corporations Act and the ASX listing rules. This code provides guidance and requirements when dealing in securities in the Company to mitigate any breach of these duties. Through the implementation of the requirements outlined in this Policy, the Company will endeavour to ensure the market is fully informed of its strategy and financial performance by seeking to provide equal access to information. The Company believes that pro-actively embracing diversity among its workforce helps it provide a workplace with greater employee satisfaction levels, enabling it to attract and retain quality people within the organisation, to better understand the market in which it operates, and to assist in achieving its corporate objectives. This policy is designed to promote and outline all reasonably practical steps required of management to place and maintain employees in an occupational environment designed to satisfy their needs for health, safety and welfare at work. The Company respects and upholds individuals' rights to privacy protection in relation to how we collect, use, disclose and hold personal information. We only collect personal information by lawful and fair means. We have detailed procedures in place to ensure that personal information is securely stored, that only authorised staff have access to it, that it remains confidential and is only used for appropriate purposes. The Remuneration and Nomination Committee (Committee) is established to advise the Board on remuneration and issues relevant to remuneration policies and practices including those for senior management and non-executive Directors. This Charter outlines the advisory role and responsibilities of the Committee. In all interactions whether in the built or virtual environment, Company Employees represent the Company and any comment made by an Employee may have implications for the Company's business. This policy has been developed to guide Company Employees as to the standards, expectations and obligations applicable to their use of social media either in the course of their employment or where using social media in a personal capacity (whether at work or elsewhere).
our locations
Vic locations
Nsw locations
Act locations
Qld locations
© 2018 Total Face Group and Website. All rights reserved.
pop_p_cross

Ask A Question
Provide your basic details below and our friendly staff will be in touch at your requested time

pop_p_cross

Schedule A Free Consultation
Provide your basic details below and our friendly staff will be in touch as soon as possible to confirm your complimentary consultation in your closest Total Face clinic.

pop_p_cross

Make An Appointment
Provide your basic details below and our friendly staff will be in touch as soon as possible to confirm your appointment in your closest Total Face clinic.

Translate »
Promotional Terms and Conditions: Vouchers are not redeemable for cash and cannot be used in conjunction with any other offer. Only one voucher redeemable per person per promotional event. Vouchers must be redeemed within their stated expiry date.